Biotech

All Articles

Exelixis loses ADC after determining it is actually no suit for Tivdak

.Exelixis is giving up on its tissue element (TF)- targeting antibody-drug conjugate after concludin...

Relay dislikes SHP2 prevention after Genentech leaves

.3 full weeks after Roche's Genentech system walked away from an SHP2 prevention contract, Relay Reh...

Stoke's Dravet disorder med launched of predisposed clinical hold

.Stoke Rehabs' Dravet disorder drug has actually been without a predisposed hold, clearing the metho...

Fierce Biotech's Gabrielle Masson provides Brutal 15 at NYSE

.Strong Biotech Colleague Editor Gabrielle Masson provided the 2024 class of Brutal 15 victors on th...

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH possibility

.Novo Nordisk has actually axed its once-monthly double GLP-1/ GIP receptor agonist, ending (PDF) de...

Daiichi pays Merck $170M to create lung cancer cells T-cell engager treaty

.Merck &amp Co. has rapidly redeemed a number of the costs of its own Harpoon Therapies acquistion, ...

BioMarin stops preclinical gene therapy for heart disease

.After BioMarin administered a springtime clean of its pipeline in April, the provider has determine...

Eisai plants molecular glue SEED with $1.5 B biobucks work

.Huge Pharmas remain caught to the suggestion of molecular adhesive degraders. The latest business t...

Life scientific research credit agency reveals with $600M

.A new global lifestyle science credit score agency, called Symbiotic Resources, has actually increa...

BMS channels TIGIT, bowing out $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing one more huge wager from the Caforio age, terminating an off...